As reported in Figure 4D , patients with higher CDK12 mRNA levels had a higher risk of recurrence (HR:1.119, 95% CI 0.9188–1.564; p = 0.179), though the difference did not reach statistical significance; no association was found for PALB2 and XPF expression levels.
← all excerpts
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.
1
—
—